CORRESP Filing
REVELATION BIOSCIENCES, INC.
Date: May 22, 2025 · CIK: 0001810560 · Accession: 0001213900-25-046811
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287423
Letter
VIA EDGAR AND E-MAIL Office of Life Sciences Division of Corporate Finance F. Street, N.E. Washington, DC 20549-7010 Re: Revelation Biosciences Inc. Registration Statement on Form S-1; Commission File No. 333-287423
Dear Mr. Campbell:
In accordance with your discussion with our counsel, we are withdrawing our acceleration request for effectiveness of the above-captioned Registration Statement dated May 20, 2025, seeking effectiveness today at 5:00 p.m. We will be submitting a new request later today seeking an effective date on Tuesday next week.
Thank you for your courtesy and cooperation in this matter.
Very truly yours,
REVELATION BIOSCIENCES, INC.
Show Raw Text
CORRESP 1 filename1.htm REVELATION BIOSCIENCES, INC. 4660 La Jolla Village Drive, Suite 100 San Diego, CA 92122 May 22, 2025 VIA EDGAR AND E-MAIL Mr. Alan Campbell Office of Life Sciences Division of Corporate Finance U.S. Securities and Exchange Commission 100 F. Street, N.E. Washington, DC 20549-7010 Re: Revelation Biosciences Inc. Registration Statement on Form S-1; Commission File No. 333-287423 Dear Mr. Campbell: In accordance with your discussion with our counsel, we are withdrawing our acceleration request for effectiveness of the above-captioned Registration Statement dated May 20, 2025, seeking effectiveness today at 5:00 p.m. We will be submitting a new request later today seeking an effective date on Tuesday next week. Thank you for your courtesy and cooperation in this matter. Very truly yours, REVELATION BIOSCIENCES, INC. By: /s/ Chester S. Zygmont, III Chester S. Zygmont, III, CFO